Tag:
T2 Biosystems
Latest Headlines
Latest Headlines
T2 Biosystems closes $23M Series D
T2 Biosystems has closed a $23 million Series D financing in a round led by new investor Aisling Capital. Aisling was joined by existing investors Flagship Ventures, Polaris Venture Partners,
T2 tech aims to ID hospital infections in fraction of the time
In a column for Forbes, Peter Cohan profiles T2 Biosystems, a company founded based on the strength of diagnostic technology developed by researchers at MIT and Massachusetts General Hospital. T2's
GSK venture group backs SpringLeaf in $15M round
SpingLeaf Therapeutics has closed a $15 million Series B round of venture capital to advance its first drug-device combination product toward the clinic, with GlaxoSmithKline's ($GSK) venture unit,
Diagnostics firm T2 Biosystems rounds up $15M in Series C
Massachusetts-based T2 Biosystems has raised $15 million in a third round of financing led by Physic Ventures. The diagnostics firm's technology combines nanotechnology and the miniaturization of
